McCarthy v. Drug Enforcement AdministrationMcCarthy v. Drug Enforcement Administration
- Reporters:
- ,
- Before:
- Chung, Phipps, Roth
OPINION*
CHUNG, Circuit Judge.
Stephen McCarthy, P.A., petitions for review of the order issued by the
I. BACKGROUND1
McCarthy is a physician assistant who held a DEA COR allowing him to prescribe Schedule II through V controlled substances. McCarthy prescribed controlled substances despite the fact that he was not being supervised by a physician with whom he had a written agreement as required by Pennsylvania law. See
On August 31, 2023, a hearing was held before ALJ Paul E. Soeffing. The DEA presented evidence that between August 24, 2022, and September 20, 2022, and again
The ALJ concluded that the DEA had therefore proven its prima facie case that McCarthy‘s continued registration was inconsistent with the public interest. Accordingly, the burden shifted to McCarthy to show that he could be entrusted with a COR. After considering McCarthy‘s failure to unequivocally admit fault, his limited remedial action, the egregiousness of his conduct, and the need for deterrence, the ALJ determined that McCarthy had not met his burden and recommended that his COR be revoked and any pending applications for renewal or modification of his COR be denied. The Administrator of the DEA adopted the ALJ‘s recommendation in its entirety and
McCarthy timely petitioned for review.
II. DISCUSSION2
McCarthy asks us to vacate the Administrator‘s order asserting that the ALJ was unconstitutionally protected from removal and that the ALJ‘s decision adopted by the Administrator was arbitrary and capricious and an abuse of discretion. We reject both arguments and will affirm.3
A. Removal Protections Challenge
DEA ALJs are removable by the Attorney General “only for good cause established and determined by the Merit Systems Protection Board.”
In order to bring a removal-protection challenge, a litigant “must show that the constitutional infirmity actually caused harm.” NLRB v. Starbucks Corp., 125 F.4th 78, 88 (3d Cir. 2024) (petitioner failed to link removal-protection infirmity to an actual harm and therefore could not bring challenge); see also CFPB v. Nat‘l Collegiate Master Student Loan Tr., 96 F.4th 599, 607 (3d Cir. 2024) (“[A]ctions taken by an improperly insulated director are not ‘void’ and do not need to be ‘ratified’ unless a plaintiff can show that the removal provision harmed him.” (quoting Collins v. Yellen, 594 U.S. 220, 259 (2021))). Stated differently, a litigant must show a causal “link” between the
B. Arbitrary and Capricious Challenge
McCarthy next argues that the Administrator‘s decision to revoke his COR was arbitrary and capricious or an abuse of discretion. See
To make this point, McCarthy primarily relies on “summaries” of eight DEA adjudications. McCarthy‘s counsel now acknowledges that seven of these summaries were inaccurate, that the eighth decision does not exist, and that the summaries and non-existent decision were all generated by Artificial Intelligence (AI). McCarthy‘s counsel further acknowledges that he never took care to confirm the accuracy of the summaries or even that the decisions existed.5 Accordingly, we will not consider this portion of his brief.6 Cf. Grant v. City of Long Beach, 96 F.4th 1255 (9th Cir. 2024) (striking brief and dismissing appeal for a similar issue).
McCarthy cites two additional cases but neither supports his position. In one case, the DEA imposed a sanction short of revocation because the respondent accepted responsibility for her actions. See Jayam Krishna-Iyer, M.D., 74 Fed. Reg. 459, 463 (DEA Jan. 6, 2009). Krishna-Iyer thus sits neatly in DEA‘s framework where a sanction
In the other case, the DEA revoked the registrant‘s COR, in part because she failed to fully take responsibility for her actions, and the D.C. Circuit denied the petition for review. See St. Croix v. Drug Enf‘t Admin., No. 21-1116, 2022 WL 2092177, at **1–2 (D.C. Cir. June 10, 2022) (per curiam). This is consistent with the DEA‘s treatment of McCarthy‘s case, wherein he was found to only partially accept responsibility for his conduct. McCarthy argues nonetheless that his behavior was less egregious than the conduct in St. Croix. Assuming that is true, it only shows the range of conduct that DEA determines to be inconsistent with the public interest and justifying a revocation, not that revocation here is a flagrant departure from DEA practice.
McCarthy briefly makes a few additional arguments that all lack merit. McCarthy argues that the Administrator failed to acknowledge the ways in which McCarthy did take responsibility. The Administrator did consider McCarthy‘s limited acceptance of responsibility, she just found it lacking.
McCarthy next argues that his COR should not have been revoked because the DEA failed to show that his misconduct resulted in the diversion of any prescribed drugs or in harm to any patients. The Administrator considered this argument, and its rejection of this argument was not an abuse of discretion. Agency precedent is clear that the DEA can find that continued registration is inconsistent with the public interest, even when a harm has not yet been realized. See Melanie Baker N.P., 86 Fed. Reg. 23,998, 24,009 (DEA May 5, 2021).
McCarthy next claims that revoking his “COR is not in the public interest insofar as he provides critical, specialized psychiatric care which is not easily replaceable.” Opening Br. 31. Again, the Administrator considered and rejected this argument consistent with DEA policy and practice. See Brenton D. Wynn, M.D., 87 Fed. Reg. 24,228, 24,258 n.KK (DEA Apr. 22, 2022). In short, the Administrator considered and
Finally, McCarthy argues that the Administrator failed to consider sanctions less drastic than revocation, such as a suspension of his COR or reprimand. That is simply not true. The Administrator considered lesser punishments but ultimately concluded that revocation was appropriate because McCarthy failed to show he could be trusted with a COR.8
III. CONCLUSION
For the forgoing reasons, we will deny the petition for review.